Siemens Healthineers has tapped the Alzheimer’s disease blood test developer ALZpath for an in vitro diagnostic to ...

The humble mammogram may soon be getting a complementary new partner to boost breast cancer screening. Liquid biopsy developer Freenome and Medtech giant Siemens Healthineers are putting their heads ...

For all its faults, Theranos did get one thing right: the now-defunct company proved that people want to have a choice of getting blood testing done in convenient, retail locations. In 2015, shortly ...

Siemens Healthineers AG became the latest company to sign a licensing agreement with Alzpath Inc. to use its pTau217 antibody in the development of a blood-based diagnostic assay for Alzheimer's ...

Siemens Healthineers will utilize ALZpath's high-performing, proprietary pTau217 antibody in its growing test menu for its Atellica analyzers to enable IVD testing for Alzheimer's disease CARLSBAD, ...

Six years after the fall of Theranos, companies are again exploring innovation in blood testing. The medical community is reacting with cautious optimism. Six years after the fall of Theranos, ...

First Study to Use a pTau217 Blood Test to Detect Alzheimer's Disease Early and at Scale CARLSBAD, Calif., Dec. 17, 2025 /PRNewswire/ -- ALZpath, Inc., a leading developer of innovative diagnostic ...

Walking through the showrooms of Siemens Healthineers, a medical tech company in Charlotte’s The Pearl district may feel like a trip inside the Star Trek starship Enterprise for the average person. A ...